TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7564973

Group type: COMPARATOR
Intervention: Water placebo (WP)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water placebo + 280 mg nicotinic acid.l‐1 (WP + NA)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 6% carbohydrate‐electrolyte beverage (CE)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CE + NA
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nicotinic acid ingestion (WP + NA and CE + NA)
Number of subjects: 10
Study: 2169782

Group type: EXPERIMENTAL
Intervention: Granisetron (40 micrograms/kg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 6927816

Group type: EXPERIMENTAL
Intervention: 250 mg Ro 13-5057
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 500 mg Ro 13-5057
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1000 mg Ro 13-5057
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 2000 mg piracetam
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31520930

Group type: EXPERIMENTAL
Intervention: Low-dose (LD) CBCT
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Standard-dose (FD) CBCT
Number of subjects: 16

Group type: COMPARATOR
Intervention: Multi-slice CT (MSCT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: MSCT
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: FD CBCT
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: LD CBCT
Number of subjects: 16
Study: 27734549

Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine (2.5 mcg·kg‐1)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Oral midazolam (0.5 mg·kg‐1)
Number of subjects: 59
Study: 26026776

Group type: EXPERIMENTAL
Intervention: Student-directed group (SDG)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Instructor-directed group (IDG)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 177
Study: 24136973

Group type: EXPERIMENTAL
Intervention: Opalescence BOOST
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: ZOOM2
Number of subjects: 22
Study: 21087463

Group type: EXPERIMENTAL
Intervention: Mebeverine (anti-spasmodic)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Methylcellulose (bulking-agent)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Regul8 with nurse telephone session and email support
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Regul8 with minimal email support
Number of subjects: 135

Group type: COMPARATOR
Intervention: No website
Number of subjects: 135
Study: 18765312

Group type: EXPERIMENTAL
Intervention: Low-dose involved-field radiation therapy (LD-IFRT) at 4 Gy in 2 fractions
Number of subjects: 36
Study: 16706811

Group type: EXPERIMENTAL
Intervention: Magnetic stimulation of the S2-S3 dermatomes
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 14
Study: 14600529

Group type: EXPERIMENTAL
Intervention: Placental malaria
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: HIV viral load
Number of subjects: 746
Study: 10973134

Group type: EXPERIMENTAL
Intervention: Perimenopausal period
Number of subjects: 25
Study: 8818847

Group type: EXPERIMENTAL
Intervention: Azithromycin 10 mg/kg once daily for 3 days
Number of subjects: 259

Group type: COMPARATOR
Intervention: Cefaclor 40 mg/kg daily in divided doses every 8 h for 10 days
Number of subjects: 259
Study: 1483372

Group type: EXPERIMENTAL
Intervention: No-stitch small incision cataract surgery
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional 3.5 mm scleral step incision
Number of subjects: 65
Study: 2933998

Group type: EXPERIMENTAL
Intervention: Procaterol 50 micrograms b.d.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Procaterol 100 micrograms b.d.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Terbutaline 5 mg t.i.d.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31780015

Group type: EXPERIMENTAL
Intervention: Abdominal massage for 30 min/day, five days a week for eight weeks
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Abdominal massage
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 35
Study: 30119284

Group type: EXPERIMENTAL
Intervention: Oral thyroxin (5 μg/kg) administered 12 hours before surgery and once daily during ICU stay
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 27467027

Group type: EXPERIMENTAL
Intervention: Active rTMS (30 sessions of low-frequency right-sided rTMS at the right DLPFC)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham rTMS (sham coil)
Number of subjects: 25
Study: 24357270

Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone
Number of subjects: 727
Study: 22525511

Group type: EXPERIMENTAL
Intervention: Ultrasound Guided BC aspiration and corticosteroid injection (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Horizontal Therapy (Group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ultrasound Guided BC aspiration and corticosteroid injection plus Horizontal therapy (Group C)
Number of subjects: 60
Study: 20860128

Group type: EXPERIMENTAL
Intervention: Fir bark splint fixation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Plaster fixation
Number of subjects: 80
Study: 19088847

Group type: COMPARATOR
Intervention: Invalid trials (invalid spatial cues)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Valid trials (valid spatial cues)
Number of subjects: 0
Study: 17955948

Group type: EXPERIMENTAL
Intervention: Physical activity at 30 W and 60 W for 4 min at 2134 m
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Physical activity at 30 W and 60 W for 4 min at 2743 m
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Physical activity at 30 W and 60 W for 4 min at sea level
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Physical activity at 30 W and 60 W for 4 min at 610 m
Number of subjects: 6
Study: 15289365

Group type: EXPERIMENTAL
Intervention: Left bundle-branch block and intraventricular conduction delay
Number of subjects: 1638

Group type: EXPERIMENTAL
Intervention: Left ventricular hypertrophy
Number of subjects: 1638

Group type: EXPERIMENTAL
Intervention: Right bundle-branch block
Number of subjects: 1638
Study: 11102555

Group type: EXPERIMENTAL
Intervention: Low eicosapentaenoic fish oil enriched formula
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 0
Study: 9311214

Group type: COMPARATOR
Intervention: Lidocaine tape applied to patients without preanesthetic medication (group N)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Lidocaine tape applied to patients who received 0.1 mg.kg‐1 of diazepam (group D)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Lidocaine tape applied to patients who received 5 micrograms.kg‐1 of clonidine (group C)
Number of subjects: 90
Study: 8346816

Group type: EXPERIMENTAL
Intervention: Ketorolac 30-60 mg IV
Number of subjects: 109

Group type: COMPARATOR
Intervention: Fentanyl 50-100 micrograms IV
Number of subjects: 109

Group type: COMPARATOR
Intervention: Combination of fentanyl 50-100 micrograms and ketorolac 30-60 mg IV
Number of subjects: 109
Study: 3787552

Group type: EXPERIMENTAL
Intervention: Vasoactive intestinal peptide (1, 3, and 6 pmol/kg/min) infused for 15 minutes
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isoprenaline (400 microgram) given by inhalation after infusion
Number of subjects: 0
Study: 31559638

Group type: EXPERIMENTAL
Intervention: CGRP monoclonal antibodies (mAbs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ditan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gepants
Number of subjects: 0
Study: 30486868

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) combined with wearable technology
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current standard in obesity treatment
Number of subjects: 0
Study: 26767548

Group type: EXPERIMENTAL
Intervention: Face-to-face group consolidation sessions
Number of subjects: 63
Study: 25186159

Group type: EXPERIMENTAL
Intervention: Pump therapy for 2 years
Number of subjects: 280

Group type: COMPARATOR
Intervention: Multiple daily injections for 2 years
Number of subjects: 280
Study: 22758620

Group type: EXPERIMENTAL
Intervention: Daytime PaO(2)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: FEV(1)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Sleep efficiency
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Rapid eye movement sleep duration
Number of subjects: 106
Study: 19290686

Group type: EXPERIMENTAL
Intervention: Low-dose beverage (target blood alcohol level = .04)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: High-dose beverage (target blood alcohol level = .08)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control group (no alcohol)
Number of subjects: 173
Study: 17500622

Group type: EXPERIMENTAL
Intervention: UV photographs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Photoaging information
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 14871515

Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Pubovaginal sling (PVS)
Number of subjects: 80
Study: 12351250

Group type: EXPERIMENTAL
Intervention: Propacetamol 2 g IV every 6 hours for 72 hours
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo IV every 6 hours for 72 hours
Number of subjects: 79
Study: 9440727

Group type: EXPERIMENTAL
Intervention: Epirubicin (EPI) 160 mg/m2 I.V. every 3 weeks
Number of subjects: 129

Group type: COMPARATOR
Intervention: Epirubicin (EPI) 160 mg/m2 I.V. every 3 weeks with DEX 1,000 mg/m2 I.V.
Number of subjects: 129
Study: 7985637

Group type: EXPERIMENTAL
Intervention: 20 mg beta-carotene/d
Number of subjects: 224

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study: 2656087

Group type: EXPERIMENTAL
Intervention: 600 mg of mifepristone + 0.5 mg gemeprost vaginal pessary
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 600 mg of mifepristone + 1 mg gemeprost vaginal pessary
Number of subjects: 120

Group type: COMPARATOR
Intervention: 1 mg gemeprost vaginal pessary
Number of subjects: 120
Study: 31928506

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 34
Study: 30711715

Group type: EXPERIMENTAL
Intervention: Bayley-III cognitive scale
Number of subjects: 1444
Study: 29151374

Group type: EXPERIMENTAL
Intervention: MDG oil with 6 mg lutein (FloraGLO 20%)
Number of subjects: 24

Group type: COMPARATOR
Intervention: SAF oil with 6 mg lutein (FloraGLO 20%)
Number of subjects: 24
Study: 25818496

Group type: EXPERIMENTAL
Intervention: Diet-and-exercise program
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 407
Study: 22882285

Group type: EXPERIMENTAL
Intervention: Intravenous human immunoglobulin (IVIG) at a dose of 500 mg/kg
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo (saline solution, 10 mL/kg)
Number of subjects: 92

Group type: COMPARATOR
Intervention: IVIG and Placebo
Number of subjects: 92
Study: 21208228

Group type: EXPERIMENTAL
Intervention: MRI integration (Group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ICE integration (Group 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MRI and ICE integration (Group 3)
Number of subjects: 60
Study: 19604500

Group type: EXPERIMENTAL
Intervention: Behavioral interventions for insomnia
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Convenient treatment options
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Beliefs about sleep promoting behaviors
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Personal beliefs about insomnia
Number of subjects: 431
Study: 18091657

Group type: EXPERIMENTAL
Intervention: Laparoscopic management of acute small bowel obstruction
Number of subjects: 0
Study: 15180117

Group type: EXPERIMENTAL
Intervention: Preoperative physiotherapy and education
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no preoperative physiotherapy or educational programme)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (study and control)
Number of subjects: 60
Study: 15450703

Group type: EXPERIMENTAL
Intervention: Moving to low-poverty neighborhoods
Number of subjects: 315

Group type: COMPARATOR
Intervention: Remaining in high-poverty neighborhoods
Number of subjects: 315
Study: 11054320

Group type: EXPERIMENTAL
Intervention: Ice test
Number of subjects: 25

Group type: COMPARATOR
Intervention: Rest test
Number of subjects: 25

Group type: COMPARATOR
Intervention: Nonmyasthenic subjects (Ice test)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Nonmyasthenic subjects (Rest test)
Number of subjects: 25
Study: 9415797

Group type: EXPERIMENTAL
Intervention: Distraction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anxiety
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anxiety x Distraction interaction
Number of subjects: 0
Study: 8180327

Group type: EXPERIMENTAL
Intervention: Reviparin-sodium (Clivarin)
Number of subjects: 498

Group type: COMPARATOR
Intervention: Enoxaparin (Lovenox)
Number of subjects: 498
Study: 3522894

Group type: EXPERIMENTAL
Intervention: Vidarabine 15 or 30 mg/kg/day
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Vidarabine
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Acyclovir (in progress)
Number of subjects: 100
Study: 29797024

Group type: EXPERIMENTAL
Intervention: Medical information sessions conducted by doctors
Number of subjects: 599

Group type: COMPARATOR
Intervention: Control group (waiting)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Medical information sessions
Number of subjects: 599
Study: 27532780

Group type: EXPERIMENTAL
Intervention: Low-concentration fish sauce (2 g/L)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: High-concentration fish sauce (8 g/L)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (no thiamine)
Number of subjects: 90
Study: 25046847

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 266
Study: 22004342

Group type: EXPERIMENTAL
Intervention: Depth first questioning (specific occurrence first)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Breadth first questioning (what usually happens first)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Episodic language use in describing an occurrence
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Episodic language use in describing what usually happens
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Accuracy rates
Number of subjects: 157
Study: 20036102

Group type: EXPERIMENTAL
Intervention: Choice (LAIV or TIV)
Number of subjects: 12222

Group type: EXPERIMENTAL
Intervention: Choice Plus (LAIV or TIV with increased advertising and nominal incentive)
Number of subjects: 12222

Group type: EXPERIMENTAL
Intervention: Choice Plus (TIV)
Number of subjects: 12222

Group type: COMPARATOR
Intervention: Control
Number of subjects: 12222
Study: 18201872

Group type: EXPERIMENTAL
Intervention: Topical retinoic acid (0.025%) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Loss of elastic fibers
Number of subjects: 0
Study: 16613276

Group type: EXPERIMENTAL
Intervention: Puerarin (500mg given 1hr before anesthesia induction)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 34
Study: 12824205

Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin (0.625 mg/d conjugated equine estrogens plus 2.5 mg/d medroxyprogesterone acetate)
Number of subjects: 16608
Study: 10480582

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 0.03% (IB)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate 0.042% (BDP)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Both IB and BDP
Number of subjects: 146
Study: 8753085

Group type: EXPERIMENTAL
Intervention: Pyloroplasty (P)
Number of subjects: 67
Study: 1984797

Group type: EXPERIMENTAL
Intervention: Leukocyte-depleted platelet concentrates prepared by filtration (mean leukocyte count < 5 x 10(6)/PC of 6 U)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Leukocyte-depleted platelet concentrates prepared by centrifugation (mean leukocyte count 35 x 10(6)/PC of 6 U)
Number of subjects: 53
Study: 6219964

Group type: EXPERIMENTAL
Intervention: Topical 1% clindamycin phosphate combined with tretinoin gel 0.025%
Number of subjects: 64

Group type: COMPARATOR
Intervention: Topical 1% clindamycin phosphate alone
Number of subjects: 64

Group type: COMPARATOR
Intervention: Tretinoin gel 0.025% alone
Number of subjects: 64
Study: 31697990

Group type: EXPERIMENTAL
Intervention: Stereotactic ablative radiation therapy (SAbR) boost, 28 Gy in 4 fractions
Number of subjects: 21
Study: 30782227

Group type: EXPERIMENTAL
Intervention: Intervention group (multimodal antimicrobial stewardship initiative)
Number of subjects: 42
Study: 28438277

Group type: EXPERIMENTAL
Intervention: Hand reflexology
Number of subjects: 80

Group type: COMPARATOR
Intervention: Simple hand massage (Control)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 80
Study: 26357426

Group type: EXPERIMENTAL
Intervention: Active Release Technique (ART)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Joint Mobilization (JM)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 23571179

Group type: EXPERIMENTAL
Intervention: HBsAg‐1018 (investigational hepatitis B surface antigen vaccine with phosphorothioate oligodeoxyribonucleotide adjuvant)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HBsAg‐1018
Number of subjects: 0

Group type: COMPARATOR
Intervention: HBsAg‐Eng (commercially available, alum‐adjuvanted hepatitis B vaccine)
Number of subjects: 0
Study: 21228629

Group type: COMPARATOR
Intervention: RIX4414 vaccine stored at 2°C‐8°C (Group RIX4414-control)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: RIX4414 vaccine stored at 37°C for 7 days (Group RIX4414-37°C)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 218
Study: 19489129

Group type: EXPERIMENTAL
Intervention: Synchro-Breathe (SB)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Volumatic (VM)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Evohaler pMDI (EH)
Number of subjects: 19
Study: 17557956

Group type: EXPERIMENTAL
Intervention: 6 months of androgen suppression therapy (AST)
Number of subjects: 1372

Group type: COMPARATOR
Intervention: 3 months of androgen suppression therapy (AST)
Number of subjects: 1372
Study: 15249101

Group type: EXPERIMENTAL
Intervention: Randomized clinical trials with appropriate randomization methods (40 articles)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Randomized clinical trials without appropriate randomization methods (31 articles)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Randomized clinical trials with inappropriate randomization methods (21 articles)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Randomized clinical trials with blinding (33 articles)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Randomized clinical trials with withdrawals/dropouts (77 articles)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: All trials
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Trials published 1992-1996
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Trials published 1997-2002
Number of subjects: 92
Study: 11942874

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg (Group M10)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Metoclopramide 20 mg (Group M20)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Saline (Group S)
Number of subjects: 45
Study: 9556321

Group type: EXPERIMENTAL
Intervention: High-calorie, high-protein diet plus protein hydrolysate (70 g/day) for Group 2 patients (n = 7)
Number of subjects: 15

Group type: COMPARATOR
Intervention: High-calorie, high-protein diet for Group 1 patients (n = 8)
Number of subjects: 15
Study: 7734029

Group type: EXPERIMENTAL
Intervention: GHRH (100 micrograms) + GHRP-6 (90 micrograms)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: GHRH (100 micrograms)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: GHRP-6 (90 micrograms)
Number of subjects: 18
Study: 2731108

Group type: EXPERIMENTAL
Intervention: Total carotenoids
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: Beta carotene
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: Serum carotenoid levels
Number of subjects: 467

Group type: COMPARATOR
Intervention: Serum levels of retinol, alpha tocopherol, and retinol‐binding protein
Number of subjects: 467
Study: 333644

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (5 grams intravenously administered 2-4 hours prior to organ harvesting)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no pretreatment)
Number of subjects: 50
Study: 7270725

Group type: EXPERIMENTAL
Intervention: 30 g of gluten daily for 5 weeks
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo challenge for 8 weeks
Number of subjects: 8
Study: 30300282

Group type: EXPERIMENTAL
Intervention: TIMP‐2/mOsm on day‐1
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: TIMP‐2/mOsm on day‐10
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 24-hour urinary creatinine excretion and TIMP‐2/mOsm on day 1
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 24-hour urinary creatinine excretion, TIMP‐2/mOsm, and total warm ischemia time on day 10
Number of subjects: 74
Study: 29737803

Group type: EXPERIMENTAL
Intervention: Kiwifruit extract (Zyactinase)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 28127798

Group type: EXPERIMENTAL
Intervention: Close friend condition
Number of subjects: 131

Group type: COMPARATOR
Intervention: Casual friend condition
Number of subjects: 131
Study: 24582813

Group type: EXPERIMENTAL
Intervention: BQ-123 (400 nmol/min for 60 min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 22790978

Group type: EXPERIMENTAL
Intervention: Postoperative autologous blood transfusion (ABT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No drainage
Number of subjects: 100